Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients

Por Fossard, Gaëlle, Blond, Emilie, Balsat, Marie, Morisset, Stéphane, Giraudier, Stéphane, Escoffre-Barbe, Martine, Labussière-Wallet, Hélène, Heiblig, Maël, Bert, Arthur, Etienne, Madeleine, Drai, Jocelyne, Sobh, Mohamad, Redonnet-Vernhet, Isabelle, Lega, Jean-Christophe, Mahon, François-Xavier, Etienne, Gabriel, Nicolini, Franck Emmanuel
Publicado no Haematologica (2016)